10x Genomics (MEX:TXG) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


MEX:TXG 10x Genomics Inc MEX:TXG
68 GF Score
Price MXN335.54
GF Value MXN200.14
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

10x Genomics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

MEX:TXG vs WAY, DOCS, HNGE: Margin of Safety % (DCF FCF Based) Comparison

For the Health Information Services subindustry, 10x Genomics's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10x Genomics Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where 10x Genomics's Margin of Safety % (DCF FCF Based) falls into.


MEX:TXG
68GF Score
10x Genomics Inc MEX:TXG
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 10x Genomics (MEX:TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of MXN335.54 is trading 67.7% above its estimated GF Value™ of MXN200.14.

Key valuation signals for MEX:TXG:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: MXN200.14 vs. price of MXN335.54 (67.7% above fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
68GF Score

Get the complete analysis for MEX:TXG

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN335.54
Price
MXN200.14
GF Value